Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration.
Buemi
M
M
Department of Internal Medicine, Institute of Neurosurgery and Institute of Pharmacology, University of Messina, Italy.
Allegra
A
A
Corica
F
F
Floccari
F
F
D'Avella
D
D
Aloisi
C
C
Calapai
G
G
Iacopino
G
G
Frisina
N
N
D000328:Adult; D001812:Blood-Brain Barrier; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004573:Electrolytes / Q000097:blood / Q000134:cerebrospinal fluid; D004921:Erythropoietin / Q000134:cerebrospinal fluid* / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007432:Intraoperative Period; D011674:Pulse; D011994:Recombinant Proteins / Q000627:therapeutic use; D012888:Skull Neoplasms / Q000601:surgery; D017585:Ultrasonography, Doppler, Transcranial
D004573:Electrolytes; D011994:Recombinant Proteins; D004921:Erythropoietin